Literature DB >> 7926759

An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.

Y Y Chen1, L C Wang, M S Huang, N Rosenberg.   

Abstract

Lymphoid cells transformed by Abelson murine leukemia virus have provided one of the classic models for study of early B-cell development and immunoglobulin rearrangement. Most of these cells have rearranged their heavy-chain locus but not their light chain genes, suggesting that an active v-abl protein interferes with this differentiation step. To test this hypothesis, light-chain gene structure was examined in pre-B cells transformed by temperature-sensitive mutants of the Abelson virus and in derivatives that survive at the nonpermissive temperature because they express a human BCL-2 gene. Our studies reveal that inactivation of the v-abl protein tyrosine kinase triggers high-frequency rearrangement of kappa and lambda light-chain genes. These events are accompanied by marked increases in the expression of RAG-1 and RAG-2 RNAs. These increases occur in the absence of protein synthesis but are dependent on inactivation of the v-abl protein tyrosine kinase. As documented in the accompanying paper (Klug et al., this issue), an active v-abl protein also suppresses the activity of NF-kappa B/rel and expression controlled by the kappa intron enhancer. Together these data demonstrate that the v-abl protein specifically interferes with light-chain gene rearrangement by suppressing at least two pathways essential for this stage of B-cell differentiation and suggest that tyrosine phosphorylation is important in regulating RAG gene expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926759     DOI: 10.1101/gad.8.6.688

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  55 in total

Review 1.  Regulation of antigen receptor gene assembly in lymphocytes.

Authors:  E M Oltz
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

3.  Two novel human and mouse DNA polymerases of the polX family.

Authors:  S Aoufouchi; E Flatter; A Dahan; A Faili; B Bertocci; S Storck; F Delbos; L Cocea; N Gupta; J C Weill; C A Reynaud
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

4.  Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.

Authors:  S Lew; D Franco; Y Chang
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

5.  Histone 3 lysine 4 methylation during the pre-B to immature B-cell transition.

Authors:  Eric J Perkins; Barbara L Kee; Dale A Ramsden
Journal:  Nucleic Acids Res       Date:  2004-03-29       Impact factor: 16.971

6.  Genomic instability due to V(D)J recombination-associated transposition.

Authors:  Yeturu V R Reddy; Eric J Perkins; Dale A Ramsden
Journal:  Genes Dev       Date:  2006-06-15       Impact factor: 11.361

7.  T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells.

Authors:  Yoshihiro Ueda; Dongmei Liao; Kaiyong Yang; Anjali Patel; Garnett Kelsoe
Journal:  J Immunol       Date:  2007-03-15       Impact factor: 5.422

8.  OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.

Authors:  X F Qin; A Reichlin; Y Luo; R G Roeder; M C Nussenzweig
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

9.  Transcriptional activation of a ras-like gene (kir) by oncogenic tyrosine kinases.

Authors:  L Cohen; R Mohr; Y Y Chen; M Huang; R Kato; D Dorin; F Tamanoi; A Goga; D Afar; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

10.  Prospective estimation of recombination signal efficiency and identification of functional cryptic signals in the genome by statistical modeling.

Authors:  Lindsay G Cowell; Marco Davila; Kaiyong Yang; Thomas B Kepler; Garnett Kelsoe
Journal:  J Exp Med       Date:  2003-01-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.